NIH-funded research NIH-funded research

National Mesothelioma Virtual Bank — patient biosamples and data network

Official title: Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) - 2021

Funded at University of Pittsburgh at Pittsburgh · NIH-11121710 · Data updated 2026-11-12

Collects and shares tissue, blood, and medical information from people with mesothelioma to help researchers develop better tests and treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 1, 2021
Project endAugust 31, 2026
Funding year2025
Award (this year)$1,100,000
NIH project number5U24OH009077-19
Project IDNIH-11121710 on NIH RePORTER

Who could benefit from this research

Could help

Adults diagnosed with mesothelioma who are willing to donate blood or tissue and share clinical and occupational history at one of the participating centers.

Less likely to help

People without mesothelioma or those unwilling or unable to provide samples or medical records would not directly participate or receive personal medical benefit from this biobank.

What this research studies

If I join, the NMVB asks me to donate tissue and blood and to share my medical records, job history, and imaging so researchers can study mesothelioma. The program links those samples with protein, genomic, and imaging data and is coordinated by the University of Pittsburgh with partner hospitals. They plan to expand the bank to about 2,200 patients and add Baylor College of Medicine to increase geographic and racial diversity. The team is also working to speed and standardize data entry by extracting clinical and pathology details from electronic health records.

Why it matters

Potential benefit: Could help researchers find new biomarkers and treatments more quickly and make studies more relevant to people like you.

How similar studies have gone: Other cancer biobanks have successfully supported biomarker discovery and treatment research, and this effort expands the existing NMVB network.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Becich, Michael John — University of Pittsburgh at Pittsburgh
  • Study coordinator: Becich, Michael John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.